Transfusion and Haematology Today - Issue 1/2006
Comprehensive Reports, Original Papers, Case Reports
			
		   6
		
	
	
																																																																		
					
					
		
							Real cost of chronic myeloid leukemia treatment with nonmyeloablative hematopoietic stem cell transplantation and comparison with cost of hypothetical imatinib treatment. What shall be considered in the cases of extremely costly medical procedures?
					
					
J. Mayer, Y. Brychtová, M. Doubek, M. Krejčí, J. Vorlíček
			
		   14
		
	
	
																																																																																																																														
					
					
		
							The use of alemtuzumab in allogeneic stem cell transplantation
					
					
J. Mayer, Y. Brychtová
			
		   20
		
	
	
																																																																																																																																																																																																																								
					
					
		
							Immunophenotyping of childhood leukaemias
					
					
T. Kalina, E. Mejstříková, M. Vášková, O. Hrušák
			
		   26
		
	
	
																																				
					
					
		
							Optimalization of extracellular fetal DNA isolation for non-invasive fetal SRY, RHD and RHCE genotyping from maternal peripheral blood
					
					
I. Hromadníková, L. Žejšková, K. Veselá, M. Vydrová, J. Doucha, R. Schrollová, D. Wagenknecht
			
		   31
		
	
	
																																																																																																																																																																																																																								
					
					
			
		   37
		
	
	
													
		
							Plasmatic concentration of soluble endoglin in patients with lymphoid malignancies
					
					
L. Smolej, C. Andrýs, D. Belada, V. Maisnar, P. Žák, O. Široký, J. Malý
Transfusion and Haematology Today
					2006 Issue 1
Most read in this issue
- Real cost of chronic myeloid leukemia treatment with nonmyeloablative hematopoietic stem cell transplantation and comparison with cost of hypothetical imatinib treatment. What shall be considered in the cases of extremely costly medical procedures?
 - Transmission of prion disease by blood and hot news in detection methods of abnormal prion protein
 - Immunophenotyping of childhood leukaemias
 - The use of alemtuzumab in allogeneic stem cell transplantation